Accreditation Statements

Ethical MedTech EU Compliance

EthicalMedTech logo

EthicalMedTech is a platform, supported by MedTech Europe, dedicated to ethics and compliance projects in the European MedTech industry.

WORLDSymposium™ 2021 has been found to be Compliant in accordance with the principles and standards set out in the MedTech Europe Code of Ethical Business Practice. This decision is posted on www.ethicalmedtech.eu.

WORLDSymposium™ 2021 Genetic Counselor CEUs

Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized WORLDSymposia, LLC to offer up to 1.947 CEUs or 19.47 Category 1 contact hours for the activity 17th Annual WORLDSymposium 2021. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

(3.0 CEUs for Emerging Trends and 16.47 CEUs for WORLDSymposium 2021)

Genetic Counselors will be required to complete the online Evaluation on CME University (www.cmeuniversity.com) in order to receive a certificate.  Instructions will be provided in the virtual platform. The online evaluation should be completed within 2 weeks post-conference. Please note, you are required to pay the NSGC Fee of $25 at the time of registration in order to obtain NSGC Credit; if you did not pay the fee, you may not receive the NSGC CEU Credits. Upon completion of the online Evaluation, you will receive a Certificate of Completion, however, the Certificate of Credit will come directly from NSGC, you MUST include your NSGC number when you complete the online evaluation. If you have any questions, email Angela Meader at: angela@nullworldsymposia.org.

2021 ACCME & ANCC Accreditation

Postgraduate Institute for Medicine
WORLDSymposium 2021 is jointly provided by Postgraduate Institute for Medicine and WORLDSymposium™.

Target Audience:
This activity has been designed for geneticists, pediatricians, primary care practitioners, registered nurses, nurse practitioners, physician assistants, genetic counselors, and other researchers and health care practitioners involved with the identification of disease mechanisms and potential treatments, or involved with the diagnosis and management of individuals with lysosomal diseases. In addition, the content is designed to be applicable to individuals with lysosomal diseases and their family members, as well as advocacy groups involved with raising awareness.

Educational Objectives:
At the completion of this program, the participant should be able to:

  • Identify the key diagnostic features of lysosomal diseases.
  • Utilize recent diagnostic tests for lysosomal diseases.
  • Compare the relative advantages and disadvantages of each therapy currently available.
  • Identify unmet needs of each disease being discussed.
  • Formulate new research ideas for these lysosomal diseases.
  • Describe the impact on, and changes to, lysosomal and rare disease research due to the COVID-19 pandemic. 

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and WORLDSymposium. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education:
The Postgraduate Institute for Medicine designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 11.0 contact hours.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.